Clinical Trial Update: Erlotinib and Radiation Therapy in Treating Older Patients With Stage I, Stage II, Stage III, or Stage IV Esophageal Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating erlotinib in combination with radiation therapy for older patients with esophageal cancer; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• Tarceva (erlotinib)

Snippet

Sponsor: Roswell Park Cancer Institute | Conditions: Esophageal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2015-03-05